1. Market Research
  2. > Healthcare Market Trends
Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market - Global Industry Analysis and Opportunity Assessment, 2020-2030

Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market - Global Industry Analysis and Opportunity Assessment, 2020-2030

  • June 2020
  • 345 pages
  • ID: 5953977
  • Format: PDF
  • Future Market Insight Global & Consulting Pvt Ltd

Summary

Table of Contents

Methicillin-resistant Staphylococcus aureus (MRSA) Treatment Market: Global Industry Analysis 2015-2019 & Opportunity Assessment 2020-2030
A recent market study published on the MRSA treatment market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics and Covid-19 crisis impact analysis. After conducting a thorough research on the historical as well as current growth parameters of the market, the growth prospects of the market are obtained with maximum precision.

MRSA Treatment Market: Segmentation
The global MRSA treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Drug Class

Glycopeptides
Vancomycin
Lipopeptides
Daptomycin
Oxazolidinones
Linezolid
Glycylcycline
Tigecycline
Streptogramins
Quinupristin
Dalfopristin
Lincomycin
Clindamycin
Tetracycline
Doxycycline
Minocycline
Lipoglycopeptides
Dalbavancin
Telavancin
Oritavancin
Antiseptics
Chlorhexidine
Cetylpyridinium Chloride
Hydrogen Peroxide
Phenols
Naturals/Herbals
Others

Route of Administration

Intravenous
Oral
Topical
Nasal
Cutaneous
Intramuscular

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drugstores
Online Pharmacies
Indication

Skin and Soft Tissue Infections (SSTIs)
Pneumonia
Bloodstream Infections
Surgical and Medical Infections
Others

Types of MRSA

Healthcare Acquired MRSA
Community Acquired MRSA
Hospital Acquired MRSA

Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the MRSA treatment market, which includes a summary of key findings and statistics of the market. It also includes supply-side and demand-side trends pertaining to the MRSA treatment market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the MRSA treatment market in this chapter, which will help them understand the basic information about the MRSA treatment market. Along with this, comprehensive information pertaining to drug class of MRSA treatment products and their features are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the MRSA treatment market report.

Chapter 03 – Key Market Trends

MRSA treatment market report provides the key market trends that are expected to significantly impact market growth during the forecast period. Detailed industry trends are provided in this section.

Chapter 04 – Market Background

This section introduces readers to the historical and current scenario of the market. An assessment on the key watershed moments in the market has been outlined, to bring readers up-to-date on the current scenario.

Chapter 05 – Market Context

This section offers key information on the product USP/features, epidemiological forecast for MRSA (2014-2024). Other key points where this market touches upon are pipeline assessment, new product approvals, and clinical trial assessments. Product adoption/route of administration analysis is also covered in detail in the study

This section explains the global market value analysis and forecast for the MRSA treatment market during the forecast period. This chapter includes a detailed analysis of the historical MRSA treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 6 - Global MRSA Treatment Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

This chapter gives information about COVID-19 crisis impact analysis which comprises of current COVID-19 statistics and probable future impact, impact on GDP of individual key countries, segment wise impact, quarter-wise forecast and projected recovery quarter. In addition, this chapter includes drivers and restraints of the MRSA treatment market. This section also includes macroeconomic factors and various opportunities of the MRSA treatment market.

Chapter 07 – Global MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Drug Class

Based on drug class, MRSA treatment market is segmented into glycopeptides, lipopeptide, oxazolidinones, glycylcycline, streptogramins, lincomycin, tetracycline, lipoglycopeptides, antiseptics, naturals/herbals, and others. In this chapter, readers can find information about Y-o-Y growth and market attractiveness analysis based on drug class.

Chapter 08 – Global MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Indication

Based on indication, MRSA treatment market is segmented into skin and soft tissue infections (SSTIs), pneumonia, bloodstream infections, surgical and medical infections, and others. In this chapter, readers can understand the Y-o-Y growth and market attractiveness analysis based on indication.

Chapter 09 - Global MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Route of Administration

Based on route of administration, MRSA treatment market is segmented into intravenous, oral, topical, nasal, cutaneous, and intramuscular. In this chapter, readers can understand the Y-o-Y growth and market attractiveness analysis based on route of administration.

Chapter 10 – Global MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Types of MRSA

Based on types of MRSA, MRSA treatment market is segmented into healthcare acquired MRSA, community acquired MRSA, and hospital acquired MRSA. In this chapter, readers can understand the Y-o-Y growth and market attractiveness analysis based on types of MRSA.

Chapter 11 – Global MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Distribution Channel

Based on distribution channel, MRSA treatment market is segmented into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. In this chapter, readers can understand the Y-o-Y growth and market attractiveness analysis based on distribution channel.

Chapter 12 – Global MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Region

This chapter explains how the MRSA treatment market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).

Chapter 13 – North America MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter includes a detailed analysis of growth of the North America MRSA treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the drug class, indication, route of administration, types of MRSA, distribution channels, and countries in North America.

Chapter 14 – Latin America MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the MRSA treatment market in Latin American countries such as Brazil, Mexico, Argentina and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 15 – Europe MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

Important growth prospects of the MRSA treatment market based on its distribution channels in several countries such as the U.K., France, Germany, Spain, Italy, Russia and the Rest of Europe are included in this chapter.

Chapter 16 – South Asia MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

Important growth prospects of the MRSA treatment market based on its distribution channels in several countries such as India, Thailand, Indonesia, Malaysia and the rest of South Asia are included in this chapter.

Chapter 17 – East Asia MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

In this chapter, China, Japan and South Korea are the prominent countries in East Asia that are the prime subjects of assessment to obtain the growth prospects of the MRSA treatment market. Readers can find detailed information about the growth parameters of the MRSA treatment market during the forecast period of 2020-2030.

Chapter 18 – Middle East & Africa (MEA) MRSA Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides information about how the MRSA treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2020-2030.

Chapter 19 – Emerging Countries MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030

This section highlights the growth prospects of the MRSA treatment market for Australia and New Zealand, during the forecast period of 2020-2030.

Chapter 20 – Key Countries MRSA Treatment Market Analysis 2015-2019 and Forecast 2020-2030

This section analyzes the MRSA treatment in key countries around the globe, offering an analysis on the key factors and developments

Chapter 21 – Market Structure Analysis

This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in MRSA treatment market.

Chapter 22 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the MRSA treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured are Pfizer, Inc. (U. S.), Allergan Plc. (U. S.), Johnsons & Johnson (U. S.), Merck & Co., Inc. (U. S.), Novartis AG (Switzerland), Baxter Healthcare Corporation (U. S.), Fresenius Kabi LLC (Germany), Bausch Health Companies Inc. (Canada), Cumberland Pharmaceuticals Inc. (U. S.), Melinta Therapeutics, Inc. (U. S.), Teva Pharmaceutical Industries Ltd. (Israel), Mylan N.V. (U. S.), Dr. Reddy’s Laboratories Ltd. (India), Akron Pharma Inc. (U. S.), Mayne Pharma Group Limited. (Australia), Sun Pharmaceutical Industries Ltd. (India), Amneal Pharmaceuticals, Inc. (U. S.), Debiopharm International SA (Switzerland), Herbal Intervention, LLC (U. S.), Bio-Germ Protection LLC (U. S.), and others.

Chapter 23 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the MRSA treatment market report.

Chapter 24 – Research Methodology
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the MRSA treatment market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Methicillin-Resistant Staphylococcus Aureus Drugs Market Research Report by Drug Class, MOA, Drug Origin, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 3949
  • April 2022
  • 184 pages

Methicillin-Resistant Staphylococcus Aureus Drugs Market Research Report by Drug Class (Cephalosporin, Folate Antagonist, and Lipoglycopeptide), MOA, Drug Origin, Region (Americas, Asia-Pacific, and Europe, ...

  • World
  • Antibiotic Resistance
  • Industry analysis

ref:plp2020

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on